Anhui BBCA Pharmaceuticals Co., Ltd is located in China’s beautiful province, Anhui, which has more than 2200 years’ history. Anhui province is an inland province near river and sea, in the east of China, next to the Yangtze River Delta Economic Area centering in Shanghai. It has beautiful natural views and profound cultural details, with a total area of 139.6 thousand sq. km, and a total population of 62 million. It has discernible seasons and mild climate. The world natural and cultural heritage Huang Mountain is just located in Anhui. AnHui BBCA Pharmaceutical Co., Ltd. is the mainstay subsidiary of BBCA Group which is found in 1960s. BBCA Pharmaceuticals is located in the capital of Anhui province, Hefei. It is the largest pharmaceutical enterprise in Anhui. BBCA is the high technology enterprise determined by The Ministry of Science and Technology and Chinese Academy of Sciences, as well as the national GMP certified enterprise and the ‘People-trusted drug brand’ awarded by Chinese government in 2006. Beside, BBCA Pharm has won the honorable title of China’s TOP 100 Pharmaceutical Industries for several years since 2006. It was listed in Sep 4, 2000 in Shenzhen stock Exchange after obtaining the approval of China Securities Regulatory Commission. Up to the end of 2008, the company had more than 4500 employees and a total capital of about 18.25 billion RMB. BBCA Pharmaceuticals is constituted of three systems which are pharmaceutical R&D, production, and sale. It has 5 pharmaceutical plants and 45 GMP certified production line, mainly involving R&D, production and sale of biological pharmacy, chemical pharmacy, and traditional Chinese medicine,and possessing nine classes of products including antipyretic-analgesic drug, cardiovascular drug, antibiotic, nervous system drug,anti-tumor drug, antiulcer drug, hormones drug, nutriceutical,and preparation of traditional Chinese medicine,etc. BBCA Pharmaceuticals can produce 11 kinds of dosage form, including large-volume injection, small-volume injection, powder injection, capsules, powders, tablets, granules, films, eye drops, patches, etc, 395 varieties, as well as many kinds of material drugs. There are more than 40 varieties of national new drugs being researched and developed, some of which have come into the market. BBCA Pharmaceuticals has many varieties of the first and second national new medicine and has the independent intellectual property of the products and various production technologies. While pursuing scale and series production. BBCA carried out the strategy of omnidirectional market cultivation and development. It has set up the sales offices in more than 30 provinces, municipalities and autonomous regions all over the country. Depending on BBCA advanced technology and abundant strength, BBCA Pharm exports products to all over the world, including Europe, North America, Africa, Southeast Asia and Central Asia.